Triple negative breast cancer accounts for 15% of cases but causes a disproportionate number of deaths. Learn about symptoms ...
Mutant KRAS in ctDNA in patients with localized pancreatic cancer was shown to be a biomarker for metastatic progression and ...
News-Medical.Net on MSN5d
Breast cancer survivors face accelerated aging tied to tumors and treatmentAccelerated aging in breast cancer survivors is linked to treatments and tumor characteristics, with implications for ...
Dr. Kevin Kalinsky discusses the role of targeted therapy and clinical decision-making in managing estrogen-driven, ...
A urinary DNA methylation test showed potential for detecting high-grade or invasive bladder cancer, according to results of ...
In metastatic triple-negative breast cancer, sacituzumab govitecan was effective and tolerable in the real-world setting.
ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements.
Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...
In today's Morning Rounds newsletter, proposed cuts to cancer research under the Trump administration, a fake CDC page with ...
“A new era in genetic testing has arrived,” said Carlos Bustamante, Ph.D., CEO & Co-Founder, Galatea Bio. “StrataRisk PRS empowers clinical genetic labs to deliver more informative reports to ...
Only 45.5% of patients completed guideline-concordant surveillance within 30 months after treatment for high-grade cervical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback